Management

Boron Molecular aspires to:

"Be a world leader in the provision of unique building-block molecules and specialist chemistry services to the pharmaceutical, fine chemicals and materials industries"

MR KEN SULLIVAN, DIRECTOR OF SALES AND MARKETING

Ken Sullivan, Director of Sales and Marketing, is based at Boron Molecular’s sales office in Raleigh, NC, USA. A graduate of North Carolina State University, Mr.Sullivan joined  Boron Molecular in September 2004 through an agency agreement between Boron and an entity controlled by Mr. Sullivan.  A highly skilled sales and operations professional, Mr. Sullivan has extensive experience selling research chemicals to organizations around the world.

DR NURUL QUAZI, PRODUCTION AND PRODUCT DEVELOPMENT MANAGER

Dr. Quazi is an experienced scientist with 25 years of industrial/academic research experience. His background spans a broad spectrum of biological and chemical fields, including molecular biology, material engineering and chemical synthesis contributing to his leadership of various multidisciplinary teams. Dr. Quazi maintains strong links with a number of Academic research groups, and has supervised a number of Ph. D candidates.  As  Product Development manager for Boron Molecular, Dr. Quazi has personally been responsible for the development of over 150 new products. Dr. Quazi holds a BSc (Hons) and MSc. in Chemistry from Jahangirnagar University and a Ph.D. in Synthetic Organic Chemistry from the LaTrobe University. He is an author on 30 publications, including inventor on 3 issued patents.

DR. JUSTINE WALTER, OPERATIONS MANAGER

Dr Justine Walter completed a PhD in synthetic organic chemistry at the University of Melbourne and undertook postdoctoral studies in the UK and at CSIRO in the fields of nanotechnology and medicinal chemistry. Justine has 14 years experience in the pharmaceutical industry where she gained expertise in the development, scale-up and manufacture of active pharmaceutical ingredients under cGMP. She has led manufacturing projects in collaboration with global pharmaceutical companies and biotechnology companies in Australia, US and UK.  She is an experienced process chemist with a demonstrated ability to solve analytical and technical problems in order to meet the customer’s deadlines and product quality requirements. Justine is based at Boron Molecular’s manufacturing site in Melbourne as Operations Manager.

DR ANTHONY KAYE, GENERAL MANAGER

Dr. Anthony Kaye, General Manager is based at Boron Molecular’s manufacturing facility located in Melbourne, Australia.  Anthony completed a Ph.D. in Synthetic Organic Chemistry, after which he undertook postdoctoral studies in medicinal chemistry specialising in the design and synthesis of anticancer drugs.  Anthony joined Boron Molecular after spending 15 years in the development and manufacture of high-potency active pharmaceutical ingredients under conditions of containment and isolation in a cGMP environment.  During this time Anthony led the successful introduction to manufacture of  API's for a broad range of international clients.

Anthony is an experienced manufacturing professional with a strong track record of international success in the contract manufacture, analysis and marketing of a wide range of products into the fine chemical and pharmaceutical industries. His experience and problem-solving skills developed in the pharmaceutical industry will play an important part in delivering products and services to Boron Molecular’s diverse client base.